Readers' and author's responses to "Are traditional peer-reviewed medical articles obsolete?" [1]

MedGenMed Medscape General Medicine

Volumn 8, Issue 1, 2006, Pages

  Goodman, Michael J ^a   Giustini, Dean ^b   Goldstone, Robert A ^a   Ward, Jerry Ann ^a   Frishauf, Peter ^a  

^a UBC Biomedical Branch ^*

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

ALERTNESS; AUTISM; CONSENSUS; DRUG SAFETY; LETTER; MEDICAL LITERATURE; PEER REVIEW; PUBLICATION; INTERNET; NOTE; PUBLISHING;

INTERNET; PEER REVIEW, RESEARCH; PUBLISHING;

EID: 33645031716     PISSN: 15310132     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (22)

1. Frishauf P. Are traditional peer-reviewed medical articles obsolete? MedGenMed. 2006;8:5. Available at: http://www.medscape.com/viewarticle/520070 Accessed January 6, 2006.
2. Geier MR, Geier DA. Thimerosal in childhood vaccines, neurodevelopment disorders, and heart disease in the United States. J Am Physicians Surg. 2003;8:6-11.
3. Institute of Medicine. Board on Health Promotion and Disease Prevention and Institute of Medicine. Immunization Safety Review Committee. Immunization safety review: vaccines and autism. Washington, DC: National Academies Press; 2004:199.
4. Parker SK, Schwartz B, Todd J, Pickering LK. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics. 2004; 114:793-804.
5. Lewis E, Shinefield HR, Woodruff BA, et al. Safety of neonatal hepatitis B vaccine administration. Pediatr Infect Dis J. 2001;20:1049-1054.
6. Verstraeten T, Davis RL, DeStefano F, et al. Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. Pediatrics. 2003;112:1039-1048.
7. Jackson LA, Austin G, Chen RT, et al. Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors. Vaccine. 2001;19:4703-4709.
8. Black S, Shinefield H, Ray P, et al. Risk of hospitalization because of aseptic meningitis after measles-mumps-rubella vaccination in one- to two-year-old children: an analysis of the Vaccine Safety Datalink (VSD) Project. Pediatr Infect Dis J. 1997;16:500-503.
9. Chen RT, Pool V, Takahashi H, Weniger BG, Patel B. Combination vaccines: postlicensure safety evaluation. Clin Infect Dis. 2001;33(suppl4):S327-333.
10. Davis RL, Marcuse E, Black S, et al. MMR2 immunization at 4 to 5 years and 10 to 12 years of age: a comparison of adverse clinical events after immunization in the Vaccine Safety Datalink project. The Vaccine Safety Datalink Team. Pediatrics. 1997;100:767-771.11.
11. Davis RL, Kolczak M, Lewis E, et al. Active surveillance of vaccine safety: a system to detect early signs of adverse events. Epidemiology. 2005;16:336-341.
12. Davis RL, Kramarz P, Bohlke K, et al. Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: a case-control study from the Vaccine Safety Datalink project. Arch Pediatr Adolesc Med. 2001;155:354-359.
13. DeStefano F, Mullooly JP, Okoro CA, et al. Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus. Pediatrics. 2001;108:E112.
14. Eriksen EM, Perlman JA, Miller A, et al. Lack of association between hepatitis B birth immunization and neonatal death: a population-based study from the vaccine safety datalink project. Pediatr Infect Dis J.2004;23:656-662.
15. Bohlke K, Davis RL, Marcy SM, et al. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics. 2003;112:815-820.
16. Jackson LA, Nelson JC, Whitney CG, et al. Assessment of the safety of a third dose of pneumococcal polysaccharide vaccine in the Vaccine Safety Datalink population. Vaccine. 2006;24:151-156.
17. Kramarz P, DeStefano F, Gargiullo PM, et al. Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma. Vaccine Safety Datalink Team. Arch Fam Med. 2000;9:617-623.
18. Niu MT, Rhodes P, Salive M, et al. Comparative safety of two recombinant hepatitis B vaccines in children: data from the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink (VSD). J Clin Epidemiol. 1998;51:503-510.
19. Ray P, Black S, Shinefield H, et al. Risk of chronic arthropathy among women after rubella vaccination. Vaccine Safety Datalink Team. JAMA. 1997;278:551-556.
20. Plesner AM. Allergic reactions to Japanese encephalitis vaccine. Immunol Allergy Clin North Am. 2003;23:665-697.
21. DeStefano F. The Vaccine Safety Datalink project. Pharmacoepidemiol Drug Saf. 2001;10:403-406.
22. Kramarz; P, DeStefano F, Gargiullo PM, et al. Influenza vaccination in children with asthma in health maintenance organizations. Vaccine Safety Datalink Team. Vaccine. 2000;18:2288-2294.